Bristol-Myers Squibb Co. (BMY) PT Lowered to $41 at Barclays
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $64.38 +0.86%
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
Barclays analyst Carter Gould lowered the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $41.00 (from $43.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Guggenheim Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)
- Maxis Bhd (MAXIS:MK) (MAXSF) PT Raised to MYR3.82 at Nomura/Instinet
- Shimao Property Holdings Limited (813:HK) (SIOPF) PT Lowered to HK$0.05 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
